CDK5 and Huntington disease: Notably, we confirmed data from a previous report42 that CHIR99021 only weakly inhibited CDK5 enzymatic activity in vitro (IC50 = 5.58 μM) (Supplementary Fig. 4i), suggesting that the effects of CHIR99021 on CDK5 activation in HD cells were indirect.